📈 Stocks
Novo, Lilly Brace for Ozempic Patent Expirations, Seek Next Blockbuster
(3 days ago)
Novo Nordisk and Eli Lilly stocks come under scrutiny as impending Ozempic and Mounjaro patent expirations threaten the GLP-1 revenue stream, forcing…